Albidom L 75mg/40mg Capsule SR
Marketer
Albinis Biotech Pvt Ltd
Salt Composition
Levosulpiride (75mg) + Pantoprazole (40mg)
Overview Albidom L 75mg/40mg Capsule SR
Gastroesophageal reflux disease (GERD), characterized by symptoms like heartburn and abdominal discomfort, is effectively managed with Albidom L 75mg/40mg SR Capsules. This medication neutralizes stomach acid, easing symptoms and facilitating gas expulsion. Dosage and duration are determined by your physician based on individual needs and response. Consistent use, as prescribed, is crucial; premature discontinuation may lead to symptom recurrence and disease progression. Always inform your doctor of all other medications you're using, as interactions are possible. Common, typically transient, side effects include nausea, vomiting, diarrhea, headache, fever, rash, abdominal pain, and flatulence. Report any concerning side effects promptly. Dizziness is a potential side effect; avoid driving or activities requiring alertness until its impact is known. Alcohol consumption should be avoided due to potential dizziness exacerbation. Lifestyle changes, such as consuming cool milk and avoiding stimulants like coffee, tea, spicy foods, and chocolate, may enhance treatment efficacy. Prior to commencing treatment, disclose any kidney conditions, pregnancy, pregnancy planning, or breastfeeding to your physician.
Uses of Albidom L 75mg/40mg Capsule SR
Managing gastroesophageal reflux disease (GERD)
Major Benefits of Albidom L 75mg/40mg Capsule SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Albidom L 75mg/40mg SR capsule whole; do not crush, chew, or break it. Administer this medication on an empty stomach.
Common Side effects of Albidom L 75mg/40mg Capsule SR:
- Stomach pain
- Vomiting
- Diarrhea
- Headache
- Nausea
- Flatulence
- Fundic gland polyps
- Fever
- Skin rash
- Dizziness
How to use Albidom L 75mg/40mg Capsule SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Albidom L 75mg/40mg SR Capsules. Ingest the capsules whole; do not crush, chew, or break them. Administer on an empty stomach.
How Albidom L 75mg/40mg Capsule SR works:
Each Albidom L 75mg/40mg sustained-release capsule contains levosulpiride and pantoprazole, a dual-drug formulation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Albidom L 75mg/40mg sustained-release capsules and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Using Albidom L 75mg/40mg sustained-release capsules during pregnancy poses a confirmed risk to the fetus. While generally contraindicated, a physician might exceptionally prescribe it in critical circumstances where the potential advantages outweigh the known dangers. Always seek medical advice.
Breast feedingUNSAFE
Extended-release Albidom L 75mg/40mg capsules are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.
DrivingUNSAFE
Driving ability may be impaired by Albidom L 75mg/40mg SR Capsules, which can induce drowsiness, dizziness, or dyskinesia. Patients should refrain from driving or operating machinery requiring alertness.
KidneyCAUTION
The extended-release Albidom L 75mg/40mg capsules require careful administration for individuals suffering from severe renal impairment. Dosage modification of Albidom L 75mg/40mg capsules may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Albidom L 75mg/40mg sustained-release capsules. Dosage modification of Albidom L 75mg/40mg sustained-release capsules may be necessary. Physician consultation is recommended.
What if you forget to take Albidom L 75mg/40mg Capsule SR :
Should you forget to take a scheduled Albidom L 75mg/40mg Capsule SR, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Albidom L 75mg/40mg Capsule SR
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Medication Classification | Digestive system |
3,018 People bought this recently